Steven J. Swanson

RPX (United States) — United States

Medicine · Health Sciences

32h-index4.3kcitations120works3.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(62), Biosimilars and Bioanalytical Methods(55), Protein purification and stability(22), CAR-T cell therapy research(18), Immunotherapy and Immune Responses(16)

Publications119 total

Abstract C038: Impact of assessment schedules on atezolizumab anti-drug antibody incidence rates
Cancer Immunology Research·2026
2025 White Paper on Recent Issues in Bioanalysis: Redosing Patients with AAV Gene Therapy; CRS Immunogenicity Risk; Shedding Assays; NHP Studies Immunogenicity; CMC vs Bioanalytical Assays; Artificial Intelligence-Powered Genomic Pipelines for NGS ( <u>PART 3A</u> – Recommendations on Gene, Cell, and Vaccine Therapies Immunogenicity &amp; Technologies; Biotherapeutics &amp; Biosimilars Immunogenicity Assessment &amp; Clinical Relevance <u>PART 3B</u> – Regulatory Agencies’ Input on Immunogenicity/Technologies of Biotherapeutics, Gene, Cell &amp; Vaccine Therapies)
Bioanalysis·2025Open Access
Interpreting immunogenicity in oncology clinical trials
Cancer Treatment Reviews·2025Open Access
Correction: Immunogenicity of Atezolizumab: Influence of Testing Method and Sampling Frequency on Reported Anti-drug Antibody Incidence Rates
The AAPS Journal·2025Open Access
Evaluating the Immunogenicity Risk of Protein Therapeutics by Augmenting T Cell Epitope Prediction with Clinical Factors
The AAPS Journal·2025· 6 citedOpen Access
What are clinically significant anti-drug antibodies and why is it important to identify them
Frontiers in Immunology·2024· 12 citedOpen Access
Immunogenicity of Atezolizumab: Influence of Testing Method and Sampling Frequency on Reported Anti-drug Antibody Incidence Rates
The AAPS Journal·2024· 6 citedOpen Access
The immunogenicity of human-origin therapeutic antibodies are associated with V gene usage
Frontiers in Immunology·2023· 11 citedOpen Access
2022 White Paper on Recent Issues in Bioanalysis: Fda Draft Guidance on Immunogenicity Information in Prescription Drug Labeling, Lnp &amp; Viral Vectors Therapeutics/Vaccines Immunogenicity, Prolongation Effect, Ada Affinity, Risk-Based Approaches, Ngs, Qpcr, Ddpcr Assays ( <u>Part 3</u> – Recommendations on Gene Therapy, Cell Therapy, Vaccines Immunogenicity &amp; Technologies; Immunogenicity &amp; Risk Assessment of Biotherapeutics and Novel Modalities; NAb Assays Integrated Approach)
Bioanalysis·2023· 14 cited
Data from An Anticancer Drug Cocktail of Three Kinase Inhibitors Improved Response to a Dendritic Cell–Based Cancer Vaccine
2023Open Access
Supplementary Table 1 from An Anticancer Drug Cocktail of Three Kinase Inhibitors Improved Response to a Dendritic Cell–Based Cancer Vaccine
2023Open Access
Supplementary Figure 1 from An Anticancer Drug Cocktail of Three Kinase Inhibitors Improved Response to a Dendritic Cell–Based Cancer Vaccine
2023Open Access
Supplementary Figure 2 from An Anticancer Drug Cocktail of Three Kinase Inhibitors Improved Response to a Dendritic Cell–Based Cancer Vaccine
2023Open Access
Supplementary Figure 1 from An Anticancer Drug Cocktail of Three Kinase Inhibitors Improved Response to a Dendritic Cell–Based Cancer Vaccine
2023Open Access
Supplementary Table 1 from An Anticancer Drug Cocktail of Three Kinase Inhibitors Improved Response to a Dendritic Cell–Based Cancer Vaccine
2023Open Access
Supplementary Figure 2 from An Anticancer Drug Cocktail of Three Kinase Inhibitors Improved Response to a Dendritic Cell–Based Cancer Vaccine
2023Open Access
Data from An Anticancer Drug Cocktail of Three Kinase Inhibitors Improved Response to a Dendritic Cell–Based Cancer Vaccine
2023Open Access
Immunogenicity of Therapeutic Proteins
2021· 1 cited
Process Safety Management Course Development
2020· 1 citedOpen Access
Integrating Electrical Contracting Industry Into The Architectural Engineering Educational Setting To Promote Learning
2020Open Access
page 1 of 6Next →

Frequent Co-authors

Daniel T. Mytych(10), Narendra Chirmule(9), Eugen Koren(6), Michael Moxness(6), Shalini Gupta(5), Suzanna Tatarewicz(5), Vibha Jawa(4), Dohan Weeraratne(4), John Ferbas(4), Troy E. Barger(4), Anthony R. Mire‐Sluis(3), Viswanath Devanarayan(3), Elizabeth W. Shores(3), Boris Gorovits(3), James A. Lofgren(3), Arunan Kaliyaperumal(3), Binodh DeSilva(3), Lei Zhou(3), Andrew J. Kuck(3), Marta Starcevic(3)